Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RUNX1 Familial Platelet Disorder”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Early research (Phase 1)Looking for participantsNCT06414889
What this trial is testing

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

Who this might be right for
RUNX1 Familial Platelet Disorder
M.D. Anderson Cancer Center 4
Early research (Phase 1)Looking for participantsNCT06090669
What this trial is testing

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Who this might be right for
Inherited Bone Marrow Failure SyndromeFamilial Platelet Disorder With Predisposition to Myeloid Malignancies
National Cancer Institute (NCI) 75
Not applicableLooking for participantsNCT03854318
What this trial is testing

Longitudinal Studies of Patient With FPDMM

Who this might be right for
Inherited Hematological DiseasesRare DiseasesFPDMM
National Human Genome Research Institute (NHGRI) 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06261060
What this trial is testing

Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

Who this might be right for
Familial Platelet DisorderHematopoietic
M.D. Anderson Cancer Center 6